[HTML][HTML] Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization …

JX Xu, DH Wu, LW Ying, HG Hu - World Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract According to the 2019 World Health Organization (WHO) classification, well-
differentiated grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are …

Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification

JX Xu, DH Wu, LW Ying, HG Hu - World journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
According to the 2019 World Health Organization (WHO) classification, well-differentiated
grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are a new …

[HTML][HTML] Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization …

JX Xu, DH Wu, LW Ying, HG Hu - World Journal of Gastroenterology, 2021 - wjgnet.com
Abstract According to the 2019 World Health Organization (WHO) classification, well-
differentiated grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are …

Immunotherapies for well-differentiated grade 3 gastroenteropancreatic neuroendocrine tumors: A new category in the World Health Organization classification.

JX Xu, DH Wu, LW Ying, HG Hu - World Journal of …, 2021 - europepmc.org
Abstract According to the 2019 World Health Organization (WHO) classification, well-
differentiated grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are …

[PDF][PDF] WJG

JX Xu, DH Wu, LW Ying, HG Hu - World J Gastroenterol, 2021 - pdfs.semanticscholar.org
Abstract According to the 2019 World Health Organization (WHO) classification,
welldifferentiated grade 3 (G3) gastroenteropancreatic (GEP) neuroendocrine tumors …